Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
13.62
-0.46 (-3.27%)
Mar 12, 2026, 10:23 AM EDT - Market open
Wave Life Sciences Market Cap
Wave Life Sciences has a market cap or net worth of $2.56 billion as of March 12, 2026. Its market cap has increased by 60.41% in one year.
Market Cap
2.56B
Enterprise Value
2.07B
1-Year Change
60.41%
Ranking
Category
Stock Price
$13.62
Market Cap Chart
Since November 11, 2015, Wave Life Sciences's market cap has increased from $334.93M to $2.56B, an increase of 665.54%. That is a compound annual growth rate of 21.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 2.59B | -16.79% |
| Dec 31, 2025 | 3.11B | 64.89% |
| Dec 31, 2024 | 1.89B | 213.58% |
| Dec 29, 2023 | 601.65M | -1.10% |
| Dec 30, 2022 | 608.37M | 229.32% |
| Dec 31, 2021 | 184.73M | -51.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 3.05B |
| Arcus Biosciences | 3.05B |
| Viridian Therapeutics | 3.04B |
| Beam Therapeutics | 2.68B |
| Travere Therapeutics | 2.67B |
| Telix Pharmaceuticals | 2.63B |
| Apellis Pharmaceuticals | 2.51B |
| Disc Medicine | 2.49B |